- Home
- EBMT vs CRBU Comparison
EBMT vs CRBU Comparison
Compare EBMT & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EBMT | CRBU |
|---|---|---|
| Founded | 1922 | 2011 |
| Country | United States | United States |
| Employees | 385 | N/A |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 178.7M | 192.4M |
| IPO Year | 2009 | 2021 |
Fundamental Metrics
Financial Performance| Metric | EBMT | CRBU |
|---|---|---|
| Price | $22.21 | $1.99 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $24.00 | $10.75 |
| AVG Volume (30 Days) | 38.8K | ★ 1.4M |
| Earning Date | 04-28-2026 | 05-08-2026 |
| Dividend Yield | ★ 2.55% | N/A |
| EPS Growth | ★ 53.23 | 3.64 |
| EPS | ★ 0.51 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $1.63 |
| Revenue Next Year | $5.00 | $10.93 |
| P/E Ratio | $44.02 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $15.11 | $0.77 |
| 52 Week High | $23.95 | $3.53 |
Technical Indicators
Market Signals| Indicator | EBMT | CRBU |
|---|---|---|
| Relative Strength Index (RSI) | 52.48 | 49.69 |
| Support Level | $21.59 | $1.70 |
| Resistance Level | $22.72 | $2.06 |
| Average True Range (ATR) | 0.72 | 0.12 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 30.15 | 28.57 |
Price Performance
Historical ComparisonAbout EBMT Eagle Bancorp Montana Inc.
Eagle Bancorp Montana Inc operates as a bank holding company. It provides loan and deposit services. The company focuses on residential loans, commercial real estate loans, commercial loans, consumer loans, and home equity loan products. The bank also offers deposit accounts which include checking, savings, money market, individual retirement accounts, and certificates of deposit accounts. It is a diversified lender with a focus on residential mortgage loans, commercial real estate mortgage loans, commercial business loans, agricultural loans, and second mortgage/home equity loan products.
About CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company is focused on advancing two clinical-stage allogeneic CAR-T cell therapy product candidates for the treatment of patients with hematologic malignancies: Vispacabtagene regedleucel and CB-011. It operates in one reportable segment, which is the business of developing allogeneic CAR-T cell therapies. Geographically, it operates in the United States and the rest of the World, of which the United States derives the maximum revenue.